Valeo Pharma (TSE:VPH) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Valeo Pharma Inc., a Canadian pharmaceutical firm, is delisting its Class A shares from the OTCQB Venture Market due to low trading volume and high costs, focusing instead on the TSX and FSE markets. This strategic move, aimed to consolidate trading platforms, was announced by CEO Al Moghaddam, highlighting the TSX’s senior status and advanced trading system.
For further insights into TSE:VPH stock, check out TipRanks’ Stock Analysis page.